Sign in with Google. Opens in new tab
bullish

MetaVia

MTVA: DA-1241 in Combination with Efruxifermin Shows Additive Hepatoprotective Effects in Mouse MASH Model

205 Views24 Jun 2025 18:00
Issuer-paid
On June 21, 2025, MetaVia Inc. (MTVA) announced the presentation of preclinical data for DA-1241, the company's novel GPR119 agonist, that showed...
What is covered in the Full Insight:
  • Introduction
  • Methods and Materials
  • Results
  • Discussion
  • Financial Overview
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x